LIFT-project for innovative antibiotics and herbicides
Groningen researchers Prof. Anna Hirsch of the Stratingh Institute for Chemistry and Dr. Matthew Groves of the Groningen Research Institute of Pharmacy and Dr. Gudrun Lange of Bayer CropScience have been awarded the LIFT project ‘On the way to innovative antibiotics and herbicides Antibiotic’. The project was granted EUR 285,000 by the NWO Chemical Sciences. Hirsch and Groves will design new molecules that inhibit an essential enzyme for the growth of pathogenic bacteria and weeds in a specific way.
LIFT is a new public-private partnership form that was introduced in 2015. A LIFT project involves at least one company and one research institute both working in chemical research. The NWO Chemical Sciences has contribute a total of EUR 1.5 million to eight LIFT projects and businesses match EUR 500,000.
On the way to innovative antibiotics and herbicides
Resistance to antibiotics and herbicides is currently a serious problem. The researchers will design new molecules that inhibit an essential enzyme for the growth of pathogenic bacteria and weeds in a specific way . To do so, they will first elucidate the structure of the enzyme, after which they will adopt a rational design approach to obtain new inhibitors. Ultimately, the inhibitors can be developed to better antibiotic or herbicides with a completely new mechanism of action.
Last modified: | 31 January 2017 11.14 p.m. |
More news
-
28 April 2025
Engineering Smart Decisions for a Dynamic World
Dynamical systems, i.e. mathematical models that describe how things evolve over time, are at the heart of much of the modern world. The real challenge, however, lies in shaping the systems’ behaviour to achieve a specific goal.
-
25 April 2025
Leading microbiologist Arnold Driessen honoured
On 25 April 2025, Arnold Driessen (Horst, the Netherlands, 1958) received a Royal Decoration. Driessen is Professor of Molecular Microbiology and chair of the Molecular Microbiology research department of the Faculty of Science and Engineering at the...
-
24 April 2025
Highlighted papers April 2025
The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers.